Penile Squamous Cell Carcinoma

• CLINICAL_TRIALS trial_result · 2025-12-02
  Clinical Trial Update: Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers [Phase 1, Phase 2]

  This update reports results from a Phase Ib/II study of TG4001 in combination with Avelumab in HPV16-positive recurrent/metastatic cancers, …

• CLINICAL_TRIALS trial_result · 2025-11-17
  Clinical Trial Update: A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors [Phase 1]

  Phase 1 basket trial evaluating customized autologous TCR-T cell therapies across multiple locally advanced or metastatic solid tumors, spon…

• CLINICAL_TRIALS trial_result · 2025-05-29
  Clinical Trial Update: Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma (ORPHEUS) [Phase 2]

  Phase 2 ORPHEUS trial evaluating INCMGA00012 in penile squamous cell carcinoma has completed, with efficacy results posted.

• CLINICAL_TRIALS trial_result · 2023-04-21
  Clinical Trial Update: Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma [Phase 2]

  Phase 2 trial evaluating maintenance avelumab immunotherapy in locally advanced or metastatic penile cancer (squamous cell carcinoma).

• CLINICAL_TRIALS trial_result · 2022-06-21
  Clinical Trial Update: Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma [Phase 2]

  Phase 2 trial of pembrolizumab for advanced penile squamous cell carcinoma has been terminated; results posted in 2022.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2021-02-25
  Clinical Trial Update: Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen) [Phase 2]

  Phase 2 trial update for cabozantinib in advanced penile squamous cell carcinoma (PSCC) ongoing; current status unknown.

• CLINICAL_TRIALS trial_result · 2020-04-14
  Clinical Trial Update: Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma [Phase 2]

  Phase 2 trial of Gilotrif in advanced penile squamous cell carcinoma was terminated, with results posted in 2020.

• CLINICAL_TRIALS trial_result · 2017-06-26
  Clinical Trial Update: Oral Rigosertib for Squamous Cell Carcinoma [Phase 2]

  A Phase 2 clinical trial evaluating oral rigosertib for various squamous cell carcinomas has completed.

• CLINICAL_TRIALS trial_result · 2016-10-14
  Clinical Trial Update: Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG) [Phase 2]

  A Phase 2 trial evaluating pazopanib with weekly paclitaxel for stage IV penile squamous cell carcinoma has been terminated.